Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CymaBay Therapeutics Inc (NASDAQ:CBAY)

10.24
BATS BZX Real-Time Price
As of 2:59pm ET
 +0.10 / +0.99%
Today’s Change
1.46
Today|||52-Week Range
10.46
+11.30%
Year-to-Date
No recent news for CymaBay Therapeutics Inc.

Today’s Trading

Previous close10.14
Today’s open10.15
Day’s range10.04 - 10.46
Volume16,689
Average volume (3 months)684,477
Market cap$444.8M
Data as of 2:59pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-37.35%
Earnings growth (this year)+28.07%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book60.39

Competitors

 Today’s
change
Today’s
% change
ACETAceto Corp+0.11+1.00%
DITAMCON Distributing C...-4.55-5.00%
AGXArgan Inc+0.25+0.56%
NUSNU Skin Enterprises ...+1.68+2.46%
Data as of 2:59pm ET, 01/19/2018

Financials

Next reporting dateMarch 23, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$26.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Sujal Shah
Chief Scientific Officer &
Senior Vice President
Charles A. McWherter
Corporate headquarters
Newark, California

Forecasts